In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
HEPARIN SODIUM IN 5% DEXTROSE INJECTION is indicated for:
Confirm the selection of the correct formulation and strength prior to administration of the drug.
HEPARIN SODIUM IN 5% DEXTROSE INJECTION is available as:
The use of heparin sodium is contraindicated in patients:
Do not use this product as a "catheter lock flush" product. Heparin is supplied in various strengths. Fatal...
The following clinically significant adverse reactions are described elsewhere in the labeling:
Heparin sodium may prolong the one-stage prothrombin time. Therefore, when heparin sodium is given with dicumarol or...
There are no available...
Bleeding is the chief sign of heparin overdosage. Nosebleeds, blood in urine or tarry stools may be noted as the first...
Heparin is a heterogeneous group of straight-chain anionic mucopolysaccharides, called glycosaminoglycans having anticoagulant properties. Although others may be present, the main sugars occurring in heparin...
Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots both in vitro and in...
Long term studies in animals to evaluate the carcinogenic potential, reproduction...
Intravenous solutions with heparin sodium are available in single-dose flexible plastic containers in various sizes and concentrations as shown in the accompanying Table as follows:
Inform patients that it may take them longer than usual to stop bleeding, that they may bruise...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at (800) 438-1985.